TGFB1 and cancer: This inhibition is incomplete emphasizing that additional mechanisms, such as MMP14 on cancer cells and αV integrin on infiltrating immune cells, including CD8+ and CD4+ TIL, and DC28,36, can activate latent TGF-β within the TME.